Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00710879 · ClinicalTrials.gov registry record · NA
Evaluation of a Multi-Purpose Solution
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT00710879: Completed NA study, sponsored by Bausch & Lomb Incorporated.
NCT00710879 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00710879, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
This study evaluates a multi-purpose solution when used on a daily wear basis by currently adapted soft contact lens wearers.
Primary Outcome
Excellent = No bacterial infection suspected and no ocular pathogens detected and bacteria of normal flora \<0-103 CFU/mL. Good = No bacterial infection suspected and no ocular pathogens detected and bacteria of normal flora \<103-105 CFU/mL. Skeptical = Bacterial infection suspected and ocular pathogens detected and bacteria of normal flora ≥ 105 CFU/mL. No Efficacy = Bacterial infection definite and ocular pathogens detected and bacteria of normal flora ≥ 105 CFU/mL. Pathogens were H. aegyptiu
Interventions
- DEVICE Bausch & Lomb Multi-Purpose Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2008-07 |
| Est. Completion | 2009-02 |
| Phase | NA |
What the finished NCT00710879 record still lists
NCT00710879 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which Bausch & Lomb Multi-Purpose Solution is the first listed.
NCT00710879 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00710879 about?
NCT00710879 is a clinical study titled "Evaluation of a Multi-Purpose Solution". This study evaluates a multi-purpose solution when used on a daily wear basis by currently adapted soft contact lens wearers.
What is the current status of trial NCT00710879?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2008-07. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00710879?
The interventions under investigation include: Bausch & Lomb Multi-Purpose Solution (DEVICE).
Who is sponsoring clinical trial NCT00710879?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00710879's enrollment target sits among peer trials
180 586th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia